Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
9
HEPA Quote, Financials, Valuation and Earnings
Last price:
$0.04
Seasonality move
:
-22.25%
Day range:
$0.04 - $0.05
52-week range:
$0.04 - $56.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.19x
Volume:
833.2K
Avg. volume:
149.3K
1-year change:
-99.93%
Market cap:
$411.6K
Revenue:
--
EPS (TTM):
-$80.50
Earnings Data
Next earnings date for HEPA
Aug 13
2025
Most recent earnings per share
-$2.15
Missed by $2.15
(May 19/2025)
Consensus Estimate
--
(May 19/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
HEPA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 05/19/2025 | Q1 | -- | -- | -$2.15 | -- | -- |
| 12/31/2024 | Q4 | -- | -- | -$8.35 | -- | -- |
| 11/14/2024 | Q3 | -- | -- | -$36.00 | -- | -- |
| 08/13/2024 | Q2 | -- | -- | -$34.00 | -- | -- |
| 05/21/2024 | Q1 | -- | -- | -$28.13 | -- | -- |
| 12/31/2023 | Q4 | -- | -- | -$121.07 | -$131.50 | $10.43 |
| 11/20/2023 | Q3 | -- | -- | -$137.00 | -$156.00 | $19.00 |
| 08/14/2023 | Q2 | -- | -- | -$184.00 | -$166.17 | -$17.83 |
| 05/12/2023 | Q1 | -- | -- | -$174.00 | -$180.00 | $6.00 |
| 12/31/2022 | Q4 | -- | -- | -$131.00 | -$130.00 | -$1.00 |
| 11/14/2022 | Q3 | -- | -- | -$112.00 | -$170.00 | $58.00 |
| 08/15/2022 | Q2 | -- | -- | -$261.00 | -$120.00 | -$141.00 |
| 05/16/2022 | Q1 | -- | -- | -$91.00 | -$130.00 | $39.00 |
| 12/31/2021 | Q4 | -- | -- | -$130.00 | -- | -- |
| 11/15/2021 | Q3 | -- | -- | -$120.00 | -- | -- |
| 08/16/2021 | Q2 | -- | -- | -$100.00 | -- | -- |
| 05/14/2021 | Q1 | -- | -- | -$120.00 | -- | -- |
| 03/25/2021 | Q4 | -- | -- | -$154.74 | -- | -- |
| 11/16/2020 | Q3 | -- | -- | -$690.00 | -- | -- |
| 08/12/2020 | Q2 | -- | -- | -$580.00 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$970.00 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$588.08 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$530.00 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$1,863.00 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$6,761.05 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$9,361.67 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$38,467.24 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$26,507.07 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$17,817.80 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$18.65 | -$44.80 | $26.15 |
| 09/30/2017 | Q3 | -- | -- | -$41,540.83 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$4,800.41 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$67,421.47 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$40,227.56 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$48,655.53 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$91,338.05 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$81,614.44 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$63,134.04 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | -$124,216.46 | -- | -- |
Hepion Pharmaceuticals Earnings Questions
-
How Much did Hepion Pharmaceuticals Generate in Revenue Last Quarter?
Hepion Pharmaceuticals reported -- worth of top line sales in its most recent quarter.
-
Did Hepion Pharmaceuticals Beat Earnings Last Quarter?
Hepion Pharmaceuticals announced earnings per share of -$2.15 which represents a miss of analyst forecast a -- per share.
-
Is Hepion Pharmaceuticals Profitable?
Hepion Pharmaceuticals reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Hepion Pharmaceuticals EPS Next Year?
Hepion Pharmaceuticals's earnings are forecast to decrease from -$107.35 per share to -$11.43 per share next year representing a decrease of -98.15%.
-
When is Hepion Pharmaceuticals's Earnings Date?
Hepion Pharmaceuticals's next earnings date is August 13, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
